Onyx Biotec
add_icon

Onyx Biotec

32.80
-1.70
(-4.93%)
Market Cap
59.47 Cr
PE Ratio
12.64
Volume
12,000.00
Day High - Low
34.00 - 32.70
52W High-Low
62.45 - 28.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
59.47 Cr
EPS
3.31
PE Ratio
12.64
PB Ratio
1.12
Book Value
30.68
EBITDA
11.50
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
8.91
Debt to Equity
0.53
Forecast For
Actual

Company News

View All News
Caret
neutral
Onyx Biotec: Weak Market Debut with 11.5% Discount on ListingNov 22, 2024
Onyx Biotec listed at ₹54 on NSE SME, 11.5% below its IPO price of ₹61. The stock recovered slightly post-listing to ₹56.75. The ₹29.34 crore IPO was oversubscribed 198 times. Proceeds will be used for manufacturing upgrades, loan repayment, and corporate purposes.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,801.60
#1 4,32,264.19
39.98
#1 54,729.00
9.71
#1 10,980
16.07
62.14
6,071.00
1,61,165.97
67.21
9,712.00
18.67
2,191
-1.02
38.37
4,390.00
1,48,577.55
66.21
11,539.40
6.99
1,911
26.24
61.73
1,292.30
1,07,859.28
19.93
33,741.20
16.73
5,725
-15.28
51.79
1,314.70
1,06,197.76
23.61
28,409.50
7.12
5,291
-57.18
40.42
2,314.90
1,05,744.36
23.07
22,909.50
13.74
3,306
#1 37.44
57.99
905.90
91,154.74
#1 18.35
23,511.00
18.55
4,615
-0.32
48.43
2,138.90
88,294.88
50.56
12,744.20
#1 20.90
2,007
7.65
47.71
1,296.50
75,300.93
21.89
32,345.60
9.43
3,484
7.59
66.14
5,355.50
64,033.04
26.89
13,458.30
3.70
2,216
1.90
40.57
Growth Rate
Revenue Growth
17.07 %
Net Income Growth
38.89 %
Cash Flow Change
-6.58 %
ROE
-38.00 %
ROCE
1.02 %
EBITDA Margin (Avg.)
16.10 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
45
40
54
63
0
Expenses
39
35
45
52
0
EBITDA
6
5
9
12
0
Operating Profit %
13 %
11 %
16 %
17 %
0 %
Depreciation
1
2
2
3
0
Interest
1
1
2
2
0
Profit Before Tax
4
3
5
7
0
Tax
0
1
1
2
0
Net Profit
3
2
4
5
0
EPS in ₹
2.84
1.56
3.05
3.31
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
37
59
74
91
Fixed Assets
17
43
44
41
Current Assets
14
15
30
49
Capital Work in Progress
4
0
0
0
Investments
0
0
0
0
Other Assets
16
16
31
50
Total Equity & Liabilities
37
59
74
91
Current Liabilities
10
20
23
26
Non Current Liabilities
10
20
26
10
Total Equity
16
18
25
56
Reserve & Surplus
11
12
12
38
Share Capital
6
6
13
18

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
-0
-4
2
7
Investing Activities
-6
-23
-3
1
Operating Activities
1
2
2
1
Financing Activities
5
16
3
5

Share Holding

% Holding
Nov 2024
Mar 2025
Sept 2025
Promoter
65.10 %
65.10 %
65.10 %
FIIs
0.00 %
0.00 %
0.00 %
DIIs
0.03 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
18.96 %
18.97 %
22.64 %
Others
15.92 %
15.94 %
12.27 %
No of Share Holders
1,181
551
640

Technical Indicators

RSI(14)
Neutral
41.86
ATR(14)
Less Volatile
1.57
STOCH(9,6)
Neutral
38.20
STOCH RSI(14)
Neutral
23.90
MACD(12,26)
Bearish
-0.18
ADX(14)
Weak Trend
15.24
UO(9)
Bearish
38.49
ROC(12)
Downtrend And Accelerating
-17.90
WillR(14)
Oversold
-81.71